Evidence map›Paper›PMID 33257684›Full record

ArticleNature communications2020

An original infection model identifies host lipoprotein import as a route for blood-brain barrier crossing.

Billel Benmimoun, Florentia Papastefanaki, Bruno Périchon, Katerina Segklia, Nicolas Roby, Vivi Miriagou, Christine Schmitt, Shaynoor Dramsi, Rebecca Matsas, Pauline Spéder

Abstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Regulating metabolism to shape immune function: Lessons from Drosophila.Seminars in cell & developmental biology · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Group B Streptococcal Neonatal Meningitis.Clinical microbiology reviews · 2022
    Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. The Serine Protease Homolog, Scarface, Is Sensitive to Nutrient Availability and Modulates the Development of theThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article
  19. Frontiers in microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Billel BenmimounInstitut Pasteur, Brain Plasticity in Response to the Environment, CNRS, UMR3738, Paris, France.ORCID 0000-0001-5766-0278
Florentia PapastefanakiLaboratory of Cellular and Molecular Neurobiology-Stem Cells, Department of Neurobiology, Hellenic Pasteur Institute, Athens, Greece.ORCID 0000-0003-1237-642X
Bruno PérichonUnité de Biologie des Bactéries Pathogènes à Gram-positif, Institut Pasteur, CNRS, UMR 2001, Paris, France.ORCID 0000-0001-6620-3423
Katerina SegkliaLaboratory of Cellular and Molecular Neurobiology-Stem Cells, Department of Neurobiology, Hellenic Pasteur Institute, Athens, Greece.ORCID 0000-0002-2017-4564
Nicolas RobyInstitut Pasteur, Brain Plasticity in Response to the Environment, CNRS, UMR3738, Paris, France.ORCID 0000-0003-4024-6155
Vivi MiriagouLaboratory of Bacteriology, Department of Microbiology, Hellenic Pasteur Institute, Athens, Greece.ORCID 0000-0003-3905-0315
Christine SchmittUltrastructure UTechS Ultrastructural Bioimaging Platform, Institut Pasteur, Paris, France.
Shaynoor DramsiUnité de Biologie des Bactéries Pathogènes à Gram-positif, Institut Pasteur, CNRS, UMR 2001, Paris, France.ORCID 0000-0001-8323-3878
Rebecca MatsasLaboratory of Cellular and Molecular Neurobiology-Stem Cells, Department of Neurobiology, Hellenic Pasteur Institute, Athens, Greece.ORCID 0000-0002-4027-348X
Pauline SpéderInstitut Pasteur, Brain Plasticity in Response to the Environment, CNRS, UMR3738, Paris, France. pauline.speder@pasteur.fr.ORCID 0000-0002-2934-5841

Funding

Resource Component: Acquisition, maintenance and distribution of Drosophila stocksP40OD018537 · OD · TRUSTEES OF INDIANA UNIVERSITY · PI Annette L. Parks · 2014 to 2026
$13.5M
NIH HHS P40 OD018537
6 · The paper itself

Abstract

Pathogens able to cross the blood-brain barrier (BBB) induce long-term neurological sequelae and death. Understanding how neurotropic pathogens bypass this strong physiological barrier is a prerequisite to devise therapeutic strategies. Here we propose an innovative model of infection in the developing Drosophila brain, combining whole brain explants with in vivo systemic infection. We find that several mammalian pathogens are able to cross the Drosophila BBB, including Group B Streptococcus (GBS). Amongst GBS surface components, lipoproteins, and in particular the B leucine-rich Blr, are important for BBB crossing and virulence in Drosophila. Further, we identify (V)LDL receptor LpR2, expressed in the BBB, as a host receptor for Blr, allowing GBS translocation through endocytosis. Finally, we show that Blr is required for BBB crossing and pathogenicity in a murine model of infection. Our results demonstrate the potential of Drosophila for studying BBB crossing by pathogens and identify a new mechanism by which pathogens exploit the machinery of host barriers to generate brain infection.

Indexed as

AnimalsAnimals, Genetically ModifiedATP Binding Cassette Transporter, Subfamily BBacteriaBacterial Outer Membrane ProteinsBlood-Brain BarrierBrainDrosophilaDrosophila ProteinsEndocytosisInfectionsLarvaLipoproteinsMaleMiceReceptors, Cytoplasmic and NuclearATP Binding Cassette Transporter, Subfamily BBacterial Outer Membrane ProteinsBlr protein, Streptococcus agalactiaeDrosophila ProteinsLipoproteinsmdr65 protein, DrosophilaReceptors, Cytoplasmic and NuclearVirulence Factors

Identifiers

PMID33257684
PMCPMC7704634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.